Research and Development
NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types
February 23, 2022 Research and Development
NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
Invitae launches first CE-IVD cancer testing kits in Europe
February 16, 2022 Research and Development
Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …
AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries
February 16, 2022 Research and Development
According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …
Scientists possibly cure HIV in first-time breakthrough for virus
February 16, 2022 Research and Development
An American research team appear to have cured HIV in a woman for the first time, making her the third …
Moderna launch Omicron-specific UK vaccine study
February 16, 2022 Research and Development
Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …
FDA investigate possible increased risk of death with lymphoma medicine
February 9, 2022 Research and Development
The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …
SaNOtize breakthrough treatment 99% effective against COVID-19
February 9, 2022 Research and Development
SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …
Despite persistent need, J&J halts COVID-19 vaccine output
February 9, 2022 Research and Development
Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …
Novavax submits EUA to FDA for COVID-19 vaccine candidate
February 2, 2022 Research and Development
Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …
Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO
February 2, 2022 Research and Development
The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …
FDA approval of six-annual-dose HIV treatment
February 2, 2022 Research and Development
ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for
First European filing submission for multiple myeloma bispecific antibody
February 2, 2022 Research and Development
Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …
FDA clearance of Investigational New Drug Application for novel peanut allergy vaccine
January 26, 2022 Research and Development
Allergy Therapeutics has announced the FDA clearance of the Investigational New Drug Application (IND) for its novel virus-like particle (VLP)-based …
Highest UK COVID-19 deaths since February as Pfizer begin trials for Omicron jab
January 26, 2022 Research and Development
Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant, and has shared that it …
Maxim Biomedical receives EUA for ClearDetect COVID-19 antigen home test
January 26, 2022 Research and Development
Maxim Biomedical have received an Emergency Use Authorisation (EUA) from the FDA for their new ClearDetect COVID-19 Antigen Home Test. …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
